Closing arguments next in FTX founder Sam Bankman's fraud trial after his testimony ends

U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug

Telechips Earns TISAX Certification for Enhanced Mobility Competitiveness

China Stocks See Record Monthly Streak of Foreign Fund Exodus

Chesapeake Energy tops profit estimates as costs ease

NFL fantasy football waiver wire pickups for Week 9

Australia's NAB targets at least $633 million in lending to indigenous businesses

Japan new economic package to total about $112 billion - Asahi

Yen Plunges to 2023 Low; Asia Stocks to Open Mixed: Markets Wrap

Ternium posts 77% quarterly income boost as steel shipments jump

Browns Deshaun Watson insurance failure magnified at NFL trade deadline

Braves Rumors: Surprise free agent fits, dark-horse trade target, Acuña Jr. plans